Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 2/1/01 → 2/28/06 |
Funding
- Bristol Myers Squibb Company: $18,293.00
A randomized, double-blind, multi-center, comparative phase I study of Intravenous BMS-284756 followed by oral BMS 284756 versus intravenous ceflaxone...
- Greenberg, Richard (PI)